{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:53:42Z","timestamp":1789797222660,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"BMBF Bonn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009398","name":"RWTH Aachen University Medical Faculty","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.neuropharm.2024.109967","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T21:22:14Z","timestamp":1713820934000},"page":"109967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Analgesic effect of Botulinum toxin in neuropathic pain is sodium channel independent"],"prefix":"10.1016","volume":"253","author":[{"given":"Aylin B.","family":"Kesdo\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6358-1012","authenticated-orcid":false,"given":"Anika","family":"Neureiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnim J.","family":"Gaebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-1606","authenticated-orcid":false,"given":"Jannis","family":"K\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Lampert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7604","key":"10.1016\/j.neuropharm.2024.109967_bib1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/533452a","article-title":"1,500 scientists lift the lid on reproducibility","volume":"533","author":"Baker","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109967_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ene.13950","article-title":"European Academy of Neurology guideline on trigeminal neuralgia","volume":"26","author":"Bendtsen","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109967_bib3","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1471-4159.2009.06093.x","article-title":"Cell entry strategy of clostridial neurotoxins","volume":"109","author":"Binz","year":"2009","journal-title":"J. Neurochem."},{"issue":"6442","key":"10.1016\/j.neuropharm.2024.109967_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tripleo.2010.04.043","article-title":"Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report","volume":"111","author":"Bohluli","year":"2011","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109967_bib6","doi-asserted-by":"crossref","DOI":"10.32614\/RJ-2017-066","article-title":"glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling","volume":"9","author":"Brooks","year":"2017","journal-title":"R J."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109967_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/0333102414527648","article-title":"Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains","volume":"34","author":"Burstein","year":"2014","journal-title":"Cephalalgia"},{"issue":"335","key":"10.1016\/j.neuropharm.2024.109967_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7653","article-title":"Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia","volume":"8","author":"Cao","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-pharmtox-010818-021757","article-title":"Structure and pharmacology of voltage-gated sodium and calcium channels","volume":"60","author":"Catterall","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10289","key":"10.1016\/j.neuropharm.2024.109967_bib10","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mcn.2004.01.015","article-title":"Gating and modulation of presumptive NaV1.9 channels in enteric and spinal sensory neurons","volume":"26","author":"Coste","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"issue":"7121","key":"10.1016\/j.neuropharm.2024.109967_bib12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40122-017-0087-0","article-title":"A review of neuropathic pain: from guidelines to clinical practice","volume":"6","author":"Cruccu","year":"2017","journal-title":"Pain Ther."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.109967_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.109967_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"issue":"38","key":"10.1016\/j.neuropharm.2024.109967_bib16","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1523\/JNEUROSCI.2695-04.2004","article-title":"Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy","volume":"24","author":"Cummins","year":"2004","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109967_bib17","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1523\/JNEUROSCI.17-10-03503.1997","article-title":"Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury","volume":"17","author":"Cummins","year":"1997","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ana.22485","article-title":"Gain of function Na\u03bd1.7 mutations in idiopathic small fiber neuropathy","volume":"71","author":"Faber","year":"2012","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109967_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neuron.2006.10.006","article-title":"SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes","volume":"52","author":"Fertleman","year":"2006","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109967_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/toxins10120535","article-title":"AbobotulinumtoxinA (Dysport\u00ae), OnabotulinumtoxinA (Botox\u00ae), and IncobotulinumtoxinA (Xeomin\u00ae) neurotoxin content and potential implications for duration of response in patients","volume":"10","author":"Field","year":"2018","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109967_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109967_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J. Pain"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109967_bib25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neuron.2011.08.002","article-title":"From cradle to grave: the multiple roles of fibroblast growth factors in neural development","volume":"71","author":"Guillemot","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.109967_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8336561","article-title":"Managing chronic neuropathic pain: recent advances and new challenges","volume":"2022","author":"Hange","year":"2022","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.neuropharm.2024.109967_bib27","author":"Hartig"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109967_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes","volume":"11","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109967_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1113\/jphysiol.1952.sp004764","article-title":"A quantitative description of membrane current and its application to conduction and excitation in nerve","volume":"117","author":"Hodgkin","year":"1952","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1152\/jn.01106.2011","article-title":"Applicability of independent component analysis on high-density microelectrode array recordings","volume":"108","author":"J\u00e4ckel","year":"2012","journal-title":"J. Neurophysiol."},{"issue":"16","key":"10.1016\/j.neuropharm.2024.109967_bib31","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.2012.505","article-title":"Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis","volume":"307","author":"Jackson","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109967_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003369","article-title":"Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT\/A)","volume":"9","author":"Jacky","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.109967_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0169-328X(01)00226-1","article-title":"The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation","volume":"95","author":"Kim","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109967_bib34","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.pain.2012.05.017","article-title":"High spontaneous activity of C-nociceptors in painful polyneuropathy","volume":"153","author":"Kleggetveit","year":"2012","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109967_bib35","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1007\/s12035-021-02367-0","article-title":"Fibroblast growth factor signalling in the diseased nervous system","volume":"58","author":"Klimaschewski","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109967_bib36","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/bph.13081","article-title":"Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach","volume":"172","author":"Klint","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109967_bib37","series-title":"The Senses: A Comprehensive Reference","first-page":"120","article-title":"Sodium channels","author":"K\u00f6rner","year":"2020"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109967_bib38","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/pme.12728","article-title":"Botulinum toxin-A for painful diabetic neuropathy: a meta-analysis","volume":"16","author":"Lakhan","year":"2015","journal-title":"Pain Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/19336950.2020.1870087","article-title":"Assessing the impact of pain-linked Nav1.7 variants: an example of two variants with no biophysical effect","volume":"15","author":"Le Cann","year":"2021","journal-title":"Channels"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109967_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221156","article-title":"NaV1.6 and NaV1.7 channels are major endogenous voltage-gated sodium channels in ND7\/23 cells","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.109967_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pain.2005.05.027","article-title":"Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats","volume":"117","author":"Lindia","year":"2005","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109967_bib42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.mcn.2004.11.007","article-title":"CAP-1A is a novel linker that binds clathrin and the voltage-gated sodium channel Nav1.8","volume":"28","author":"Liu","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109967_bib43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","article-title":"Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation","volume":"101","author":"Lucioni","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.neuropharm.2024.109967_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ehb.2022.101200","article-title":"Pain trends and pain growth disparities, 2009\u20132021","volume":"47","author":"Macchia","year":"2022","journal-title":"Econ. Hum. Biol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109967_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/toxins11080459","article-title":"Mechanisms of botulinum toxin type A action on pain","volume":"11","author":"Matak","year":"2019","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109967_bib46","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/j.pain.0000000000001511","article-title":"The role of Nav1.7 in human nociceptors: insights from human induced pluripotent stem cell-derived sensory neurons of erythromelalgia patients","volume":"160","author":"Meents","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2024.109967_bib47","first-page":"37","article-title":"Studying sodium channel gating in heterologous expression systems","volume":"Bd. 113","author":"Meents","year":"2016"},{"key":"10.1016\/j.neuropharm.2024.109967_bib48","series-title":"Voltage-gated Sodium Channels: Structure, Function and Channelopathies","first-page":"125","article-title":"Sodium Channel trafficking","author":"Mercier","year":"2018"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109967_bib49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1523\/JNEUROSCI.2433-18.2018","article-title":"Resilience to pain: a peripheral component identified using induced pluripotent stem cells and dynamic clamp","volume":"39","author":"Mis","year":"2019","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1469-7793.2000.00045.x","article-title":"L-type calcium channel activity regulates sodium channel levels in rat pituitary GH3 cells","volume":"523","author":"Monjaraz","year":"2000","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109967_bib51","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1017\/S0033583500003292","article-title":"Structure and function of tetanus and botulinum neurotoxins","volume":"28","author":"Montecucco","year":"1995","journal-title":"Q. Rev. Biophys."},{"issue":"24","key":"10.1016\/j.neuropharm.2024.109967_bib52","doi-asserted-by":"crossref","first-page":"25665","DOI":"10.1074\/jbc.M311515200","article-title":"Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity","volume":"279","author":"Morenilla-Palao","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109967_bib53","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1155\/2014\/754693","article-title":"Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society","volume":"19","author":"Moulin","year":"2014","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.neuropharm.2024.109967_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ebiom.2018.11.042","article-title":"Pain relief in a neuropathy patient by lacosamide: proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors","volume":"39","author":"Namer","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib55","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0080-19.2019","article-title":"Assessment of spontaneous neuronal activity in vitro using multi-well multi-electrode arrays: implications for assay development","volume":"7","author":"Negri","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2024.109967_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-0716-1979-7_11","article-title":"Differentiation of iPS-cells into peripheral sensory neurons","volume":"2429","author":"Neureiter","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109967_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1348-0421.1995.tb02184.x","article-title":"Structure and function of Clostridium botulinum toxins","volume":"39","author":"Oguma","year":"1995","journal-title":"Microbiol. Immunol."},{"issue":"19","key":"10.1016\/j.neuropharm.2024.109967_bib58","doi-asserted-by":"crossref","first-page":"E2665","DOI":"10.1073\/pnas.1521194113","article-title":"Polarized localization of voltage-gated Na+ channels is regulated by concerted FGF13 and FGF14 action","volume":"113","author":"Pablo","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109967_bib59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF03022619","article-title":"The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain","volume":"53","author":"Park","year":"2006","journal-title":"Can. J. Anaesth. J. Can. D\u2019anesthesie"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109967_bib60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/toxins9090260","article-title":"Botulinum toxin for the treatment of neuropathic pain","volume":"9","author":"Park","year":"2017","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109967_bib61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.24122","article-title":"Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction","volume":"75","author":"Paterson","year":"2014","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109967_bib62","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0006-2952(00)00260-4","article-title":"Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms","volume":"59","author":"Purkiss","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109967_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002320001061","article-title":"Very negative potential for half-inactivation of, and effects of anions on, voltage-dependent sodium currents in acutely isolated rat olfactory receptor neurons","volume":"175","author":"Qu","year":"2000","journal-title":"J. Membr. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109967_bib64","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.21427","article-title":"Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain","volume":"64","author":"Ranoux","year":"2008","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109967_bib65","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1124\/dmd.114.059238","article-title":"Subcutaneous absorption of biotherapeutics: knowns and unknowns","volume":"42","author":"Richter","year":"2014","journal-title":"Drug Metabol. Dispos.: Biol. Fate Chem."},{"key":"10.1016\/j.neuropharm.2024.109967_bib87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2017.11.047","article-title":"Human vs. Mouse Nociceptors \u2013 similarities and differences","volume":"387","author":"Rostock","year":"2018","journal-title":"Neuroscience"},{"issue":"19","key":"10.1016\/j.neuropharm.2024.109967_bib66","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1111\/bph.15196","article-title":"Uncoupling sodium channel dimers restores the phenotype of a pain-linked Nav1.7 channel mutation","volume":"177","author":"R\u00fchlmann","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109967_bib67","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00221-003-1565-7","article-title":"GTP gamma S increases Nav1.8 current in small-diameter dorsal root ganglia neurons","volume":"152","author":"Saab","year":"2003","journal-title":"Exp. Brain Res."},{"issue":"18","key":"10.1016\/j.neuropharm.2024.109967_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cells11182905","article-title":"Human stem cell-derived TRPV1-positive sensory neurons: a new tool to study mechanisms of sensitization","volume":"11","author":"Schrenk-Siemens","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2024.109967_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3284446","article-title":"Botox (OnabotulinumtoxinA) for treatment of migraine symptoms: a systematic review","volume":"2022","author":"Shaterian","year":"2022","journal-title":"Pain Res. Manag."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109967_bib70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nbd.2012.07.010","article-title":"Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A","volume":"48","author":"Shimizu","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1254\/jphs.11060FP","article-title":"Inhibition of membrane Na+ channels by A type botulinum toxin at femtomolar concentrations in central and peripheral neurons","volume":"118","author":"Shin","year":"2012","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1358863X11422584","article-title":"Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation","volume":"17","author":"Skeik","year":"2012","journal-title":"Vasc. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109967_bib73","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2340\/00015555-0609","article-title":"Severe post-herpetic neuralgia successfully treated with botulinum toxin A: three case reports","volume":"89","author":"Sotiriou","year":"2009","journal-title":"Acta Derm. Venereol."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109967_bib74","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1074\/jbc.M114.605899","article-title":"Erythromelalgia mutation Q875E Stabilizes the activated state of sodium channel Nav1.7","volume":"290","author":"Stadler","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109967_bib75","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/ALN.0000000000000832","article-title":"Neosaxitoxin in rat sciatic block: improved therapeutic index using combinations with bupivacaine, with and without epinephrine","volume":"123","author":"Templin","year":"2015","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109967_bib76","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0006-3495(99)77296-6","article-title":"Ultra-slow inactivation in mu1 Na+ channels is produced by a structural rearrangement of the outer vestibule","volume":"76","author":"Todt","year":"1999","journal-title":"Biophys. J."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109967_bib77","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib78","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1152\/jn.1994.72.1.466","article-title":"Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy","volume":"72","author":"Waxman","year":"1994","journal-title":"J. Neurophysiol."},{"issue":"1302","key":"10.1016\/j.neuropharm.2024.109967_bib79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1098\/rspb.1990.0084","article-title":"Novel cell lines display properties of nociceptive sensory neurons","volume":"241","author":"Wood","year":"1990","journal-title":"Proc. Biol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109967_bib80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102412441721","article-title":"Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Wu","year":"2012","journal-title":"Cephalalgia: Int. J. Headache"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109967_bib81","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1526-4637.2010.01003.x","article-title":"Subcutaneous injection of botulinum toxin A is beneficial in postherpetic neuralgia","volume":"11","author":"Xiao","year":"2010","journal-title":"Pain Med."},{"key":"10.1016\/j.neuropharm.2024.109967_bib82","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34518","article-title":"A spike sorting toolbox for up to thousands of electrodes validated with ground truth recordings in vitro and in vivo","volume":"7","author":"Yger","year":"2018","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109967_bib83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/gb-2003-4-3-207","article-title":"Overview of the voltage-gated sodium channel family","volume":"4","author":"Yu","year":"2003","journal-title":"Genome Biol."},{"issue":"17","key":"10.1016\/j.neuropharm.2024.109967_bib84","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109967_bib85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1129-2377-15-65","article-title":"Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Zhang","year":"2014","journal-title":"J. Headache Pain"},{"issue":"3A","key":"10.1016\/j.neuropharm.2024.109967_bib86","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S0004-282X2008000400012","article-title":"Beneficial effects of botulinum toxin type A in trigeminal neuralgia","volume":"66","author":"Z\u00fa\u00f1iga","year":"2008","journal-title":"Arq. Neuro. Psiquiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T08:35:23Z","timestamp":1715934923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824001369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":86,"alternative-id":["S0028390824001369"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109967","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic effect of Botulinum toxin in neuropathic pain is sodium channel independent","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109967"}}